ADNI | Publications

Filter results by:

1800 Total Publications

Asymptomatic Alzheimer disease: Defining resilience.
T. J. Hohman, D. G. McLaren, E. C. Mormino, K. A. Gifford, D. J. Libon, A. L. Jefferson and I. Alzheimer's Disease Neuroimaging
PMID: 27815399 ; PMCID:5177674 ; 2016; Journal Neurology; vol. 87; no. 23; pp. 2443-2450; AWTX4SQCwAl_G9zjEvXF doi:10.1212/WNL.0000000000003397

Clusters of male and female Alzheimer’s disease patients in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database
D. Gamberger, B. Zenko, A. Mitelpunkt, N. Shachar and N. Lavrac
PMID: 27525218 ; PMCID:4963443 ; 2016; Journal Brain Inform; vol. 3; no. 3; pp. 169-179; AWTYHKVzdzjauPDbjhlu doi:10.1007/s40708-016-0035-5

Genetic Association of HLA Gene Variants with MRI Brain Structure in Alzheimer’s Disease
Z. X. Wang, Y. Wan, L. Tan, J. Liu, H. F. Wang, F. R. Sun, M. S. Tan, C. C. Tan, T. Jiang, L. Tan, J. T. Yu and I. Alzheimer's Disease Neuroimaging
PMID: 27056077 ; 2016; Journal Mol Neurobiol; vol. 54; no. 5; pp. 3195-3204; AWTYHKVzdzjauPDbjhl4 doi:10.1007/s12035-016-9889-z

Detection of Alzheimer’s disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers
C. A. DeMarshall, E. P. Nagele, A. Sarkar, N. K. Acharya, G. Godsey, E. L. Goldwaser, M. Kosciuk, U. Thayasivam, M. Han and B. Belinka
PMID: 27239548 ; PMCID:4879649 ; 2016; Journal Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring; vol. 3; pp. 51-62; AWTYEk81dzjauPDbjhkJ doi:10.1016/j.dadm.2016.03.002

CSF Aβ1–42 – an excellent but complicated Alzheimer's biomarker – a route to standardisation
J. A. Kuhlmann, A. U., J. Pannee, M. Bjerke, E. Portelius, A. Leinenbach, T. Bittner, M. Korecka, R. G. Jenkins and Vanderstichele
PMID: 27216941 ; 2016; Journal Clinica Chimica Acta; vol. 467; pp. 27-33; AWTYEEswwAl_G9zjEvYL doi:10.1016/j.cca.2016.05.014

Benzodiazepine Use Attenuates Cortical β-Amyloid and is Not Associated with Progressive Cognitive Decline in Nondemented Elderly Adults: A Pilot Study Using F18-Florbetapir Positron Emission Tomography.
J. K. Chung, S. Nakajima, S. Shinagawa, E. Plitman, M. M. Chakravarty, Y. Iwata, F. Caravaggio, B. G. Pollock, P. Gerretsen, A. Graff-Guerrero and I. Alzheimer's Disease Neuroimaging
PMID: 27538351 ; 2016; Journal Am J Geriatr Psychiatry; vol. 24; no. 11; pp. 1028-1039; AWTX5LQ2MOwVf_qbJr18 doi:10.1016/j.jagp.2016.04.013

Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging
J. Ahdidan, C. A. Raji, E. A. DeYoe, J. Mathis, K. O. Noe, J. Rimestad, T. K. Kjeldsen, J. Mosegaard, J. T. Becker and O. Lopez
PMID: 26484924 ; PMCID:4718601 ; 2016; Journal J Alzheimers Dis; vol. 49; no. 3; pp. 723-32; AWTX4BB4dzjauPDbjhib doi:10.3233/JAD-150559

Manual segmentation of the fornix, fimbria, and alveus on high-resolution 3T MRI: Application via fully-automated mapping of the human memory circuit white and grey matter in healthy and pathological aging
R. S. C. Amaral, M. T. M. Park, G. A. Devenyi, V. Lynn, J. Pipitone, J. Winterburn, S. Chavez, M. Schira, N. J. Lobaugh, A. N. Voineskos, J. C. Pruessner, M. M. Chakravarty and I. Alzheimer's Disease Neuroimaging
PMID: 27765611 ; 2016; Journal Neuroimage; vol. 170; pp. 132-150; AWTX4BB4dzjauPDbjhis doi:10.1016/j.neuroimage.2016.10.027

Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort
D. Tosun, Y. F. Chen, P. Yu, K. L. Sundell, J. Suhy, E. Siemers, A. J. Schwarz, M. W. Weiner and I. Alzheimer's Disease Neuroimaging
PMID: 27109039 ; 2016; Journal Alzheimers Dement; vol. 12; no. 9; pp. 977-986; AWTX4BB4dzjauPDbjhiy doi:10.1016/j.jalz.2016.03.009

Gene Prioritization for Imaging Genetics Studies Using Gene Ontology and a Stratified False Discovery Rate Approach
S. Patel, M. T. Park, M. M. Chakravarty and J. Knight
PMID: 27092072 ; PMCID:4823264 ; 2016; Journal Front Neuroinform; vol. 10; pp. 14; AWTYkLG3MOwVf_qbJr6z doi:10.3389/fninf.2016.00014